Compare Incyte Corporation (INCY) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Prospect Capital Corporation — how do they compare? Incyte Corporation trades at $120.45 (market cap $24.54B), while Prospect Capital Corporation trades at $2.29 (market cap $1.14B). The key difference: Incyte Corporation is far larger — about 21.5× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 21.93% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.
| INCY | PSEC | |
|---|---|---|
Market Cap | $24.54B | $1.14B |
Sector | Health | Financials |
52-Week High | $129.93 | $3.05 |
52-Week Low | $81.61 | $2.11 |
Enterprise Value | $20.04B | — |
Dividend Yield | — | 21.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
